Abstract
ENESTxtnd: Impact Of Nilotinib Dose Re-Escalation In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have